| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |